Sydney E. Salmon
Impact in
- Hematology top 0.1%
- Multiple Myeloma Research and Treatments
- Oncology top 0.2%
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
Papers in
-
- Cancer therapeutics and mechanisms 15
- Chemical Synthesis and Analysis 10
- Protein Degradation and Inhibitors 10
- Glycosylation and Glycoproteins Research 7
- Oncology 51
- Cancer Treatment and Pharmacology 21
- Co-authors
- Brian G.M. Durie (21 shared papers)Anne W. Hamburger (4 shared papers)Kit S. Lam (12 shared papers)Evan M. Hersh (8 shared papers)Richard J. Knapp (5 shared papers)Victor J. Hruby (4 shared papers)Wieslaw M. Kazmierski (2 shared papers)David S. Alberts (15 shared papers)
- Journals
- Investigational New Drugs (14 papers)Cancer (12 papers)New England Journal of Medicine (11 papers)Science (4 papers)Cancer Chemotherapy and Pharmacology (4 papers)
- Partner nations
- United StatesGermanyPortugal
In The Last Decade
Sydney E. Salmon
135 papers receiving 12.4k citations
Sydney E. Salmon's Hit Papers
Peers
Comparison fields: 5 of 157
- Hematology 4.7k
- Oncology 5.2k
- Cancer Research 1.6k
- Molecular Biology 7.0k
- Genetics 927
Countries citing papers authored by Sydney E. Salmon
This map shows the geographic impact of Sydney E. Salmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sydney E. Salmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sydney E. Salmon more than expected).
Fields of papers citing papers by Sydney E. Salmon
This network shows the impact of papers produced by Sydney E. Salmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sydney E. Salmon. The network helps show where Sydney E. Salmon may publish in the future.
Co-authors
The 25 scholars most cited alongside Sydney E. Salmon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 136 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival Hit paper breakdown → | 1975 | 2351 |
| 2 | A new type of synthetic peptide library for identifying ligand-binding activity Hit paper breakdown → | 1991 | 1449 |
| 3 | Primary Bioassay of Human Tumor Stem Cells Hit paper breakdown → | 1977 | 1309 |
| 4 | Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell Cancer Hit paper breakdown → | 2001 | 1223 |
| 5 | Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer Drugs Hit paper breakdown → | 1978 | 779 |
| 6 | Evidence for the Secretion of an Osteoclast Stimulating Factor in Myeloma Hit paper breakdown → | 1974 | 502 |
| 7 | 1997 | 415 | |
| 8 | Primary Bioassay of Human Myeloma Stem Cells Hit paper breakdown → | 1977 | 365 |
| 9 | 2006 | 339 | |
| 10 | 1975 | 171 | |
| 11 | Polyamines as markers of response and disease activity in cancer chemotherapy. | 1977 | 170 |
| 12 | 2002 | 170 | |
| 13 | 1972 | 162 | |
| 14 | Immunotherapy of Cancer: Present Status of Trials in Man | 1977 | 158 |
| 15 | 1988 | 145 | |
| 16 | 1970 | 136 | |
| 17 | 1975 | 133 | |
| 18 | Preparation of permanent slides of intact soft-agar colony cultures of hematopoietic and tumor stem cells. | 1979 | 119 |
| 19 | 1995 | 116 | |
| 20 | 1971 | 108 |
About Sydney E. Salmon
Sydney E. Salmon is a scholar working on Molecular Biology, Oncology, Hematology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 136 papers that have together received 13.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (42 papers), Cancer Treatment and Pharmacology (21 papers), Monoclonal and Polyclonal Antibodies Research (21 papers), Cancer therapeutics and mechanisms (15 papers), Chemical Synthesis and Analysis (10 papers), Protein Degradation and Inhibitors (10 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Glycosylation and Glycoproteins Research (7 papers). The work is most often cited by research in Hematology (4.7k citations), Oncology (5.2k citations), Cancer Research (1.6k citations), Molecular Biology (7.0k citations) and Genetics (927 citations). Sydney E. Salmon has collaborated with scholars based in United States, Germany and Portugal. Frequent co-authors include Brian G.M. Durie, Anne W. Hamburger, Kit S. Lam, Evan M. Hersh, Richard J. Knapp, Victor J. Hruby, Wieslaw M. Kazmierski, David S. Alberts, Thomas E. Moon and B Soehnlen. Their work appears in journals such as Investigational New Drugs, Cancer, New England Journal of Medicine, Science and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.